2.20
+0.17(+8.37%)
Currency In USD
| Previous Close | 2.03 |
| Open | 2.08 |
| Day High | 2.32 |
| Day Low | 1.96 |
| 52-Week High | 17.04 |
| 52-Week Low | 1.38 |
| Volume | 83,057 |
| Average Volume | 1.56M |
| Market Cap | 1.47M |
| PE | -0.18 |
| EPS | -12.12 |
| Moving Average 50 Days | 2.64 |
| Moving Average 200 Days | 7.37 |
| Change | 0.17 |
If you invested $1000 in NAYA Biosciences, Inc. (NAYA) since IPO date, it would be worth $1.57 as of July 10, 2025 at a share price of $2.2. Whereas If you bought $1000 worth of NAYA Biosciences, Inc. (NAYA) shares 3 years ago, it would be worth $10.66 as of July 10, 2025 at a share price of $2.2.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
GlobeNewswire Inc.
Apr 14, 2025 11:30 PM GMT
Public company to operate under new name and concentrate on building, acquiring and operating fertility clinics and the distribution of FDA-cleared INVOcell device Private company to operate as NAYA Therapeutics and focus on clinical development of b
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
GlobeNewswire Inc.
Mar 13, 2025 8:30 PM GMT
SARASOTA, Fla. and MIAMI, March 13, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases, and women’s he
NAYA Biosciences Supports Recent Executive Order Aimed at Improving Access to Fertility Treatment
GlobeNewswire Inc.
Feb 25, 2025 1:00 PM GMT
NAYA Sees Potential Positive Impact to Its Existing Fertility Operations and FDA-Cleared INVOcell TechnologySARASOTA, Fla. and MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- NAYA Biosciences, Inc. (“NAYA”) (NASDAQ: NAYA), a life science portfolio company
Data not available